Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas

导出原文传递

翻译打印收藏纠错

作者： El Sayed, Rola ^[1] ; El Darsa, Haidar ; Kort, Jeries ; Al Chami, Farouk ; Ibrahim, Ali ; Charafeddine, Maya ; Bazarbachi, Ali ; Abou Dalle, Iman ; El Cheikh, Jean

作者单位： Med Ctr,Amer Univ Beirut ^[1]

关键词 High-grade B-cell lymphoma DLBCL R-ACVBP Vindesine Vincristine NON-HODGKIN-LYMPHOMA RITUXIMAB PLUS CYCLOPHOSPHAMIDE CHOP-LIKE CHEMOTHERAPY DETUDES DES LYMPHOMES DOSE-ADJUSTED EPOCH PHASE-III TRIAL YOUNG-PATIENTS OPEN-LABEL INTENSIFIED CHEMOTHERAPY ELDERLY-PATIENTS

发布时间 2022-03-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Clinical lymphoma, myeloma & leukemia

2021年21卷10期

711-719页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas

Clinical lymphoma, myeloma & leukemia

相似文献

Clinical lymphoma, myeloma & leukemia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas

Clinical lymphoma, myeloma & leukemia

相似文献

Clinical lymphoma, myeloma & leukemia

相关期刊

检索历史清除